Payden & Rygel Q3 2022 vs. Q4 2022 Fund Comparison Analysis

As a professional blog writer, my focus is to provide well-researched content to readers. Today, I will be discussing the Payden & Rygel Q3 2022 vs. Q4 2022 13F Holdings Comparison. The Payden & Rygel Fund is a Los Angeles-based financial services company that provides investment management, financial planning, family office services, and retirement plan administration. The company's investment approach is based on research and analysis of global capital markets, and their investment philosophy is guided by an emphasis on risk management, capital preservation, and generating long-term returns. In this blog post, we will explore the changes in holdings of this fund.

Introduction

The Payden & Rygel Q3 2022 13F filing revealed a total portfolio value of $8.16 billion, with the top three holdings being UnitedHealth Group, Arthur J Gallagher & Co, and Eli Lilly & Co. The fund's Q4 2022 filing showed a total portfolio value of $8.4 billion, with the top three holdings being the same. The analysis of these holdings and other major changes within the fund is discussed in detail below.

Q3 2022 vs. Q4 2022 Holdings

The biggest change in holding is related to Amdocs Ltd, as it was not held in the third quarter, but Payden & Rygel acquired 381,300 shares in the fourth quarter, with a value of $34,660,000. The largest holding in Q3 2022 was United Health Group, and it remained the same in Q4 2022, with a total of 95,210 shares valued at $50,478,000.

The second-largest holding in Q3 2022 was Arthur J Gallagher & Co, with 211,800 shares valued at $36,264,000. In contrast, in Q4 2022, the fund reported 250,380 shares with a value of $47,207,000. This represents a 30.2% increase in the number of shares held, indicating a positive outlook for the company's growth in the future.

Merck & Co showed a 7.7% increase in the number of shares held, with 404,210 shares in Q3 2022 to 338,010 shares in Q4 2022. The value of the holding decreased from $34,811,000 to $37,502,000. However, the decrease in value could also be attributed to the decrease in Merck & Co's stock prices during this period.

Republic Services-Cl A showed a significant increase in the number of shares held, with 212,420 shares in Q3 2022 to 319,450 shares in Q4 2022. The value of the holding increased from $28,898,000 to $41,206,000. This represents a 42.6% increase in the number of shares held, indicating a positive outlook for the company's growth in the future.

General Mills showed an increase of 78.9% in the number of shares held, with 254,400 shares in Q3 2022 to 415,800 shares in Q4 2022. The value of the holding increased from $19,490,000 to $34,865,000. This increase in holdings is due to the positive outlook on the company's growth.

The largest decrease in holdings was related to Phillips 66, as it decreased by 56.7%, with 411,900 shares in Q3 2022 to 179,900 shares in Q4 2022. The value of the holding also decreased from $33,249,000 to $18,724,000. This might be due to the decrease in crude oil prices during the last quarter.

Conclusion

In conclusion, the Payden & Rygel Q3 2022 vs. Q4 2022 13F Holdings Comparison shows a few significant changes in holdings. The fund showed a positive outlook for companies such as Arthur J Gallagher & Co and Republic Services-Cl A, which saw an increase in the number of shares held. On the other hand, there was a decrease in holdings for Phillips 66 and Pfizer. It is important to note that changes in the fund's holdings are a result of continuous monitoring of the market and adjustment of the portfolio based on research and analysis of global capital markets. Investors should always research and analyze market trends before making any investment decisions.